These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34792764)

  • 21. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
    Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
    Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.
    Duncan M; Millns P; Smart D; Wright JE; Kendall DA; Ralevic V
    Br J Pharmacol; 2004 Jun; 142(3):509-18. PubMed ID: 15148262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.
    Khasabova IA; Khasabov S; Paz J; Harding-Rose C; Simone DA; Seybold VS
    J Neurosci; 2012 May; 32(20):7091-101. PubMed ID: 22593077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid system involves in the analgesic effect of protocatechuic acid.
    Dikmen DY; Okcay Y; Arslan R; Bektas N
    Daru; 2019 Dec; 27(2):605-612. PubMed ID: 31325037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention.
    Álvarez-Tosco K; González-Fernández R; González-Nicolás MÁ; Martín-Ramírez R; Morales M; Gutiérrez R; Díaz-Flores L; Arnau MR; Machín F; Ávila J; Lázaro A; Martín-Vasallo P
    BMC Neurosci; 2024 Sep; 25(1):44. PubMed ID: 39278931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.
    Ta LE; Bieber AJ; Carlton SM; Loprinzi CL; Low PA; Windebank AJ
    Mol Pain; 2010 Mar; 6():15. PubMed ID: 20205720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain.
    Pol O; Murtra P; Caracuel L; Valverde O; Puig MM; Maldonado R
    Neuropharmacology; 2006 Jan; 50(1):123-32. PubMed ID: 16360182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
    Rahn EJ; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
    J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice.
    Renn CL; Carozzi VA; Rhee P; Gallop D; Dorsey SG; Cavaletti G
    Mol Pain; 2011 Apr; 7():29. PubMed ID: 21521528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB
    Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ
    Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihyperalgesic effect of CB
    Oliveira-Fusaro MCG; Zanoni CIS; Dos Santos GG; Manzo LP; Araldi D; Bonet IJM; Tambeli CH; Dias EV; Parada CA
    Eur J Pharmacol; 2017 Mar; 798():113-121. PubMed ID: 28131783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone methyltransferase G9a diminishes expression of cannabinoid CB
    Luo Y; Zhang J; Chen L; Chen SR; Chen H; Zhang G; Pan HL
    J Biol Chem; 2020 Mar; 295(11):3553-3562. PubMed ID: 32024693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol exerts anti-oxidant and anti-inflammatory actions and prevents oxaliplatin-induced mechanical and thermal allodynia.
    Recalde MD; Miguel CA; Noya-Riobó MV; González SL; Villar MJ; Coronel MF
    Brain Res; 2020 Dec; 1748():147079. PubMed ID: 32866545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Romero TR; Resende LC; Guzzo LS; Duarte ID
    Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.
    Nasirinezhad F; Jergova S; Pearson JP; Sagen J
    Neuropharmacology; 2015 Aug; 95():100-9. PubMed ID: 25486617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
    Khasabova IA; Yao X; Paz J; Lewandowski CT; Lindberg AE; Coicou L; Burlakova N; Simone DA; Seybold VS
    Pharmacol Res; 2014 Dec; 90():67-75. PubMed ID: 25304184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocannabinoid activation of CB
    Sun L; Tai L; Qiu Q; Mitchell R; Fleetwood-Walker S; Joosten EA; Cheung CW
    Eur J Pain; 2017 May; 21(5):804-814. PubMed ID: 28107590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Participation of cannabinoid receptors in peripheral nociception induced by some NSAIDs.
    Silva LC; Romero TR; Guzzo LS; Duarte ID
    Braz J Med Biol Res; 2012 Dec; 45(12):1240-3. PubMed ID: 22983178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells reduce the oxaliplatin-induced sensory neuropathy through the reestablishment of redox homeostasis in the spinal cord.
    Dos Santos GGL; Oliveira ALL; Santos DS; do Espírito Santo RF; Silva DN; Juiz PJL; Soares MBP; Villarreal CF
    Life Sci; 2021 Jan; 265():118755. PubMed ID: 33189826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.